About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6565 record(s)
Req # A-2021-001988
All training / guidance materials, memos, and policy documents utilized by Health Canada when reviewing a Notice of New Cannabis Product submission received under the Cannabis Act. All training / guidance materials, memos, and policy documents…Organization: Health Canada
January 2025
Req # A-2023-000160
The safety summary reports of the hematological monitoring for AA-Clozapine-associated neutropenia/agranulocytosis. Date ranges: All available reports. Manufacturer: AA Pharma Inc. The request references all marketed strengths of AA-Clozapine…Organization: Health Canada
January 2025
Req # A-2023-000440
In response to OPQ #1448, Health Canada responded as follows: "The referred report [5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021. During the time period referenced…Organization: Health Canada
January 2025
Req # A-2023-000818
All correspondence between Pest Management Regulatory Agency (PMRA) staff, Corteva (formerly Dow Agroscience) and the Ethylene Bisdithiocarbamate/Ethylene Thiourea (EBDC/ETU) task force regarding mancozeb drinking water monitoring and estimated…Organization: Health Canada
January 2025
Req # A-2023-000932
Information on the review status of the Abbreviated New Drug Submission (ANDS) for liraglutide accepted into review in August 2017, including but not limited to a screen shot from Health Canada’s Drug Submission Tracking System (DSTS) for this ANDS.Organization: Health Canada
January 2025
Req # A-2023-001027
All information and documents held by Health Canada with respect to considerations of whether and how chemically synthesized drug products can use a biologic drug as the Canadian Reference Product, from January 2017 to October 30, 2023.Organization: Health Canada
January 2025
Req # A-2023-001058
Requesting contribution agreement no. 2122-HQ-000092 (reference number 271-2021-2022-Q2-00011).Organization: Health Canada
January 2025
Req # A-2023-001117
All evaluation reports and information on glyphosate or pest control products containing glyphosate from January 1, 2021 until October 31 2022.Organization: Health Canada
January 2025
Req # A-2023-001152
All documents from employees or agents of Bjornson and Associates to the Pest Management Regulatory Agency (PMRA), including Deputy Minister, Assistant Deputy Minister and the Minister's office at Health Canada and associated PMRA responses.…Organization: Health Canada
January 2025
Req # A-2023-001176
Information and documents submitted by Exegi Pharma, Limited Liability Company (LLC) to Health Canada in 2014 and 2015 seeking a Natural Health Product Licence for the Visbiome product which issued as Natural Product Number (NPN) 80061901.Organization: Health Canada
January 2025